{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:02:11Z","timestamp":1794733331501,"version":"4.9.1"},"reference-count":70,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>The expression of aldose reductase leads to a variety of biological and pathological\neffects. It is a multifunctional enzyme which has a tendency to reduce aldehydes to the corresponding\nsugar\nalcohol. In diabetic conditions, the aldose reductase enzyme converts glucose into\nsorbitol using nicotinamide adenine dinucleotide phosphate as a cofactor. It is a key enzyme in\npolyol pathway which is a surrogate course of glucose metabolism. The polyol pathway has a significant\nimpact on the aetiology of complications in individuals with end-stage diabetes. The exorbitant\nlevel of sorbitol leads to the accumulation of intracellular reactive oxygen species in diabetic\nheart, neurons, kidneys, eyes and other vasculatures, leading to many complications and pathogenesis.\nRecently, the pathophysiological role of aldose reductase has been explored with multifarious\nperspectives. Research on aldose reductase suggest that besides implying in diabetic complications,\nthe enzyme also turns down the lipid-derived aldehydes as well as their glutathione conjugates.\nAlthough aldose reductase has certain lucrative role in detoxification of toxic lipid aldehydes,\nits overexpression leads to intracellular accumulation of sorbitol which is involved in secondary\ndiabetic complications, such as neuropathy, cataractogenesis, nephropathy, retinopathy and\ncardiovascular pathogenesis. Osmotic upset and oxidative stress are produced by aldose reductase\nvia the polyol pathway. The inhibition of aldose reductase alters the activation of transcription\nfactors like NF-\u0199B. Moreover, in many preclinical studies, aldose reductase inhibitors have been\nobserved to reduce inflammation-related impediments, such as asthma, sepsis and colon cancer, in\ndiabetic subjects. Targeting aldose reductase can bestow a novel cognizance for this primordial\nenzyme as an ingenious strategy to prevent diabetic complications and associated morbidities. In\nthis review article, the significance of aldose reductase is briefly discussed along with their prospective\napplications in other afflictions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389201025666230830125147","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:49:15Z","timestamp":1693442955000},"page":"1073-1081","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The Role of Aldose Reductase in Polyol Pathway: An Emerging\nPharmacological Target in Diabetic Complications and Associated\nMorbidities"],"prefix":"10.2174","volume":"25","author":[{"given":"Jeetendra Kumar","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Institute of Pharmaceutical Research, GLA University Mathura, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/0006-3002(56)90247-5","volume":"22","author":"Hers H.G.","year":"1956","unstructured":"Hers H.G.; Le m\u00e9canisme de la transformation de glucose en fructose par les v\u00e9sicules s\u00e9minales. Biochim Biophys Acta  1956,22(1),202-203","journal-title":"Biochim Biophys Acta"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1515\/bmc.2011.002","volume":"2","author":"Ramana K.V.","year":"2011","unstructured":"Ramana K.V.; Aldose reductase: New insights for an old enzyme. Biomol Concepts  2011,2(1-2),103-114","journal-title":"Biomol Concepts"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/184194b0","volume":"184","author":"Van Heyningen R.","year":"1956","unstructured":"Van Heyningen R.; Formation of polyols by the lens of the rat with `Sugar' cataract. Nature  1956,184(4681),194-195","journal-title":"Nature"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"CD004572","DOI":"10.1002\/14651858.CD004572.pub2","volume":"2010","author":"Chalk C.","year":"2007","unstructured":"Chalk C.; Benstead T.J.; Moore F.; Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Libr  2007,2010(1),CD004572","journal-title":"Cochrane Libr"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/0304-4165(68)90305-X","volume":"158","author":"Kinoshita J.H.","year":"1968","unstructured":"Kinoshita J.H.; Dvornik D.; Kramil M.; Gabbay K.H.; The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens. Biochim Biophys Acta, Gen Subj  1968,158(3),472-475","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/0026-0495(79)90057-X","volume":"28","author":"Kinoshita J.H.","year":"1979","unstructured":"Kinoshita J.H.; Fukushi S.; Kador P.; Merola L.O.; Aldose reductase in diabetic complications of the eye. Metabolism  1979,28(4)(Suppl. 1),462-469","journal-title":"Metabolism"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.bi.50.070181.002125","volume":"50","author":"Brownlee M.","year":"1981","unstructured":"Brownlee M.; Cerami A.; The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem  1981,50(1),385-432","journal-title":"Annu Rev Biochem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0891-6632(89)90015-9","volume":"3","author":"Stribling D.","year":"1989","unstructured":"Stribling D.; Armstrong F.M.; Harrison H.E.; Aldose reductase in the etiology of diabetic complications: 2. Nephropathy. J Diabet Complications  1989,3(2),70-76","journal-title":"J Diabet Complications"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1210\/er.2004-0028","volume":"26","author":"Srivastava S.K.","year":"2005","unstructured":"Srivastava S.K.; Ramana K.V.; Bhatnagar A.; Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev  2005,26(3),380-392","journal-title":"Endocr Rev"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jdiacomp.2009.07.005","volume":"24","author":"Schemmel K.E.","year":"2010","unstructured":"Schemmel K.E.; Padiyara R.S.; D\u2019Souza J.J.; Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: A review. J Diabetes Complications  2010,24(5),354-360","journal-title":"J Diabetes Complications"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF00400627","volume":"38","author":"Yamaoka T.","year":"1995","unstructured":"Yamaoka T.; Nishimura C.; Yamashita K.; Itakura M.; Yamada T.; Fujimoto J.; Kokai Y.; Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia  1995,38(3),255-261","journal-title":"Diabetologia"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1210\/jc.83.8.2886","volume":"83","author":"Shah V.O.","year":"1998","unstructured":"Shah V.O.; Scavini M.; Nikolic J.; Sun Y.; Vai S.; Griffith J.K.; Dorin R.I.; Stidley C.; Yacoub M.; Vander Jagt D.L.; Eaton R.P.; Zager P.G.; Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab  1998,83(8),2886-2891","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1523-1755.2001.00788.x","volume":"60","author":"Hodgkinson A.D.","year":"2001","unstructured":"Hodgkinson A.D.; S\u00f8ndergaard K.L.; Yang B.; Cross D.F.; Millward B.A.; Demaine A.G.; Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy. Kidney Int  2001,60(1),211-218","journal-title":"Kidney Int"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1056-8727(03)00003-5","volume":"18","author":"Ramana K.V.","year":"2004","unstructured":"Ramana K.V.; Chandra D.; Wills N.K.; Bhatnagar A.; Srivastava S.K.; Oxidative stress-induced up-regulation of the chloride channel and Na+\/Ca2+ exchanger during cataractogenesis in diabetic rats. J Diabetes Complications  2004,18(3),177-182","journal-title":"J Diabetes Complications"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1006\/exer.1993.1139","volume":"57","author":"Bhatnagar A.","year":"1993","unstructured":"Bhatnagar A.; Ansari N.H.; Zacarias A.; Srivastava S.K.; Digital image analysis of cultured rat lens during oxidative stress-induced cataractogenesis. Exp Eye Res  1993,57(4),385-391","journal-title":"Exp Eye Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.1073\/pnas.82.21.7222","volume":"82","author":"Srivastava S.K.","year":"1985","unstructured":"Srivastava S.K.; Hair G.A.; Das B.; Activated and unactivated forms of human erythrocyte aldose reductase. Proc Natl Acad Sci USA  1985,82(21),7222-7226","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"24841","DOI":"10.1016\/S0021-9258(18)35840-X","volume":"267","author":"Borhani D.W.","year":"1992","unstructured":"Borhani D.W.; Harter T.M.; Petrash J.M.; The crystal structure of the aldose reductase.NADPH binary complex. J Biol Chem  1992,267(34),24841-24847","journal-title":"J Biol Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e74076","DOI":"10.1371\/journal.pone.0074076","volume":"8","author":"Del-Corso A.","year":"2013","unstructured":"Del-Corso A.; Balestri F.; Di Bugno E.; Moschini R.; Cappiello M.; Sartini S.; La-Motta C.; Da-Settimo F.; Mura U.; A new approach to control the enigmatic activity of aldose reductase. PLoS One  2013,8(9),e74076","journal-title":"PLoS One"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0167-4838(95)00021-L","volume":"1249","year":"1995","unstructured":"bander Jagt, D.L.; Kolb, N.S.; bander Jagt, T.J.; Chino, J.; Martinez, F.J.; Hunsaker, L.A.; Royer, R.E. Substrate specificity of human aldose reductase: Identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta Protein Struct Mol Enzymol  1995,1249(2),117-126","journal-title":"Biochim Biophys Acta Protein Struct Mol Enzymol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"21587","DOI":"10.1074\/jbc.M909235199","volume":"275","author":"Dixit B.L.","year":"2000","unstructured":"Dixit B.L.; Balendiran G.K.; Watowich S.J.; Srivastava S.; Ramana K.V.; Petrash J.M.; Bhatnagar A.; Srivastava S.K.; Kinetic and structural characterization of the glutathione-binding site of aldose reductase. J Biol Chem  2000,275(28),21587-21595","journal-title":"J Biol Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"32063","DOI":"10.1074\/jbc.M202126200","volume":"277","author":"Ramana K.V.","year":"2002","unstructured":"Ramana K.V.; Chandra D.; Srivastava S.; Bhatnagar A.; Aggarwal B.B.; Srivastava S.K.; Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem  2002,277(35),32063-32070","journal-title":"J Biol Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"9705","DOI":"10.1158\/0008-5472.CAN-06-2105","volume":"66","author":"Tammali R.","year":"2006","unstructured":"Tammali R.; Ramana K.V.; Singhal S.S.; Awasthi S.; Srivastava S.K.; Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res  2006,66(19),9705-9713","journal-title":"Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1161\/CIRCRESAHA.109.213447","volume":"106","author":"Ramasamy R.","year":"2010","unstructured":"Ramasamy R.; Goldberg I.J.; Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. Circ Res  2010,106(9),1449-1458","journal-title":"Circ Res"},{"key":"ref=24","first-page":"540","volume":"10","author":"Yadav U.C.S.","year":"2010","unstructured":"Yadav U.C.S.; Srivastava S.K.; Ramana K.V.; Understanding the role of aldose reductase in ocular inflammation. Curr Mol Med  2010,10(6),540-549","journal-title":"Curr Mol Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0026-0495(86)90180-0","volume":"35","author":"Cheng H.M.","year":"1986","unstructured":"Cheng H.M.; Gonz\u00e1lez R.G.; The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis. Metabolism  1986,35(4)(Suppl. 1),10-14","journal-title":"Metabolism"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"H75","DOI":"10.1152\/ajpcell.1998.275.1.C75","volume":"275","author":"Trueblood N.","year":"1998","unstructured":"Trueblood N.; Ramasamy R.; Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am J Physiol  1998,275(1),H75-H83","journal-title":"Am J Physiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1096\/fj.00-0652fje","volume":"15","author":"Ido Y.","year":"2001","unstructured":"Ido Y.; Chang K.; Woolsey T.A.; Williamson J.R.; NADH: Sensor of blood flow need in brain, muscle, and other tissues. FASEB J  2001,15(8),1419-1421","journal-title":"FASEB J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/diab.42.6.801","volume":"42","author":"Williamson J.R.","year":"1993","unstructured":"Williamson J.R.; Chang K.; Frangos M.; Hasan K.S.; Ido Y.; Kawamura T.; Nyengaard J.R.; Den Enden M.; Kilo C.; Tilton R.G.; Hyperglycemic pseudohypoxia and diabetic complications. Diabetes  1993,42(6),801-813","journal-title":"Diabetes"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"636267","DOI":"10.3389\/fendo.2021.636267","volume":"12","author":"Jannapureddy S.","year":"2021","unstructured":"Jannapureddy S.; Sharma M.; Yepuri G.; Schmidt A.M.; Ramasamy R.; Aldose reductase: An emerging target for development of interventions for diabetic cardiovascular complications. Front Endocrinol (Lausanne)  2021,12,636267","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0003-2670(97)00649-1","volume":"365","author":"Tanimoto T.","year":"1998","unstructured":"Tanimoto T.; Maekawa K.; Okada S.; Yabe-Nishimura C.; Clinical analysis of aldose reductase for differential diagnosis of the pathogenesis of diabetic complication. Anal Chim Acta  1998,365(1-3),285-292","journal-title":"Anal Chim Acta"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0006-2944(83)90051-0","volume":"29","author":"Markus H.B.","year":"1983","unstructured":"Markus H.B.; Raducha M.; Harris H.; Tissue distribution of mammalian aldose reductase and related enzymes. Biochem Med  1983,29(1),31-45","journal-title":"Biochem Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.2040-1124.2010.00071.x","volume":"2","author":"Hashimoto Y.","year":"2011","unstructured":"Hashimoto Y.; Yamagishi S.I.; Mizukami H.; Yabe-Nishimura C.; Lim S.W.; Kwon H.M.; Yagihashi S.; Polyol pathway and diabetic nephropathy revisited: Early tubular cell changes and glomerulopathy in diabetic mice overexpressing human aldose reductase. J Diabetes Investig  2011,2(2),111-122","journal-title":"J Diabetes Investig"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1016\/S0021-9258(17)35619-3","volume":"261","author":"MacGregor L.C.","year":"1986","unstructured":"MacGregor L.C.; Rosecan L.R.; Laties A.M.; Matschinsky F.M.; Altered retinal metabolism in diabetes. I. Microanalysis of lipid, glucose, sorbitol, and myo-inositol in the choroid and in the individual layers of the rabbit retina. J Biol Chem  1986,261(9),4046-4051","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/diab.43.2.169","volume":"43","author":"Frank R.N.","year":"1994","unstructured":"Frank R.N.; The aldose reductase controversy. Diabetes  1994,43(2),169-172","journal-title":"Diabetes"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0009-2797(00)00297-0","volume":"130-132","author":"Ramana K.V.","year":"2001","unstructured":"Ramana K.V.; Dixit B.L.; Srivastava S.; Bhatnagar A.; Balendiran G.K.; Watowich S.J.; Petrash J.M.; Srivastava S.K.; Characterization of the glutathione binding site of aldose reductase. Chem Biol Interact  2001,130-132(1-3),537-548","journal-title":"Chem Biol Interact"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"12172","DOI":"10.1021\/bi000796e","volume":"39","author":"Ramana K.V.","year":"2000","unstructured":"Ramana K.V.; Dixit B.L.; Srivastava S.; Balendiran G.K.; Srivastava S.K.; Bhatnagar A.; Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry  2000,39(40),12172-12180","journal-title":"Biochemistry"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1517\/13543784.2012.656198","volume":"21","author":"Pandey S.","year":"2012","unstructured":"Pandey S.; Srivastava S.K.; Ramana K.V.; A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases. Expert Opin Investig Drugs  2012,21(3),329-339","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1167\/iovs.13-13487","volume":"55","author":"Chang K.C.","year":"2014","unstructured":"Chang K.C.; Ponder J.; LaBarbera D.V.; Petrash J.M.; Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia. Invest Ophthalmol Vis Sci  2014,55(5),2853-2861","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/exer.1993.1119","volume":"57","author":"Sato S.","year":"1993","unstructured":"Sato S.; Lin L.R.; Reddy V.N.; Kador P.F.; Aldose reductase in human retinal pigment epithelial cells. Exp Eye Res  1993,57(2),235-241","journal-title":"Exp Eye Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.freeradbiomed.2007.01.033","volume":"42","author":"Ramana K.V.","year":"2007","unstructured":"Ramana K.V.; Reddy A.B.M.; Tammali R.; Srivastava S.K.; Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages. Free Radic Biol Med  2007,42(8),1290-1302","journal-title":"Free Radic Biol Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.113.005224","volume":"129","author":"Tang W.H.","year":"2014","unstructured":"Tang W.H.; Stitham J.; Jin Y.; Liu R.; Lee S.H.; Du J.; Atteya G.; Gleim S.; Spollett G.; Martin K.; Hwa J.; Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation  2014,129(15),1598-1609","journal-title":"Circulation"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-8227(02)00248-6","volume":"60","author":"Miwa K.","year":"2003","unstructured":"Miwa K.; Nakamura J.; Hamada Y.; Naruse K.; Nakashima E.; Kato K.; Kasuya Y.; Yasuda Y.; Kamiya H.; Hotta N.; The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract  2003,60(1),1-9","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0009-2797(00)00289-1","volume":"130-132","author":"Murata M.","year":"2001","unstructured":"Murata M.; Ohta N.; Sakurai S.; Alam S.; Tsai J.Y.; Kador P.F.; Sato S.; The role of aldose reductase in sugar cataract formation: Aldose reductase plays a key role in lens epithelial cell death (apoptosis). Chem Biol Interact  2001,130-132(1-3),617-625","journal-title":"Chem Biol Interact"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2337\/diabetes.55.04.06.db05-0932","volume":"55","author":"Srivastava S.","year":"2006","unstructured":"Srivastava S.; Ramana K.V.; Tammali R.; Srivastava S.K.; Bhatnagar A.; Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells. Diabetes  2006,55(4),901-910","journal-title":"Diabetes"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00005344-199302000-00004","volume":"21","author":"Tesfamariam B.","year":"1993","unstructured":"Tesfamariam B.; Palacino J.J.; Weisbrod R.M.; Cohen R.A.; Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol  1993,21(2),205-211","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.febslet.2004.06.046","volume":"570","author":"Ramana K.V.","year":"2004","unstructured":"Ramana K.V.; Bhatnagar A.; Srivastava S.K.; Aldose reductase regulates TNF-\u03b1-induced cell signaling and apoptosis in vascular endothelial cells. FEBS Lett  2004,570(1-3),189-194","journal-title":"FEBS Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2337\/diabetes.54.3.818","volume":"54","author":"Ramana K.V.","year":"2005","unstructured":"Ramana K.V.; Friedrich B.; Tammali R.; West M.B.; Bhatnagar A.; Srivastava S.K.; Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes  2005,54(3),818-829","journal-title":"Diabetes"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.2337\/diabetes.53.11.2910","volume":"53","author":"Ramana K.V.","year":"2004","unstructured":"Ramana K.V.; Friedrich B.; Srivastava S.; Bhatnagar A.; Srivastava S.K.; Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes  2004,53(11),2910-2920","journal-title":"Diabetes"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1210\/en.2010-0160","volume":"151","author":"Tammali R.","year":"2010","unstructured":"Tammali R.; Saxena A.; Srivastava S.K.; Ramana K.V.; Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1\/S phase transition of cell cycle. Endocrinology  2010,151(5),2140-2150","journal-title":"Endocrinology"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1535-7163.MCT-09-0795","volume":"9","author":"Ramana K.V.","year":"2010","unstructured":"Ramana K.V.; Tammali R.; Srivastava S.K.; Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT\/phosphoinositide 3-kinase\/E2F-1 pathway in human colon cancer cells. Mol Cancer Ther  2010,9(4),813-824","journal-title":"Mol Cancer Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1210\/en.2008-0677","volume":"150","author":"Reddy A.B.M.","year":"2009","unstructured":"Reddy A.B.M.; Ramana K.V.; Srivastava S.; Bhatnagar A.; Srivastava S.K.; Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-\u03b1 via protein kinase C-\u03b4 and TNF-\u03b1 converting enzyme in vascular smooth muscle cells. Endocrinology  2009,150(1),63-74","journal-title":"Endocrinology"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1210\/en.2007-0512","volume":"148","author":"Ramana K.V.","year":"2007","unstructured":"Ramana K.V.; Tammali R.; Reddy A.B.M.; Bhatnagar A.; Srivastava S.K.; Aldose reductase-regulated tumor necrosis factor-alpha production is essential for high glucose-induced vascular smooth muscle cell growth. Endocrinology  2007,148(9),4371-4384","journal-title":"Endocrinology"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3420187","volume":"2018","author":"Wu M.Y.","year":"2018","unstructured":"Wu M.Y.; Yiang G.T.; Lai T.T.; Li C.J.; The oxidative stress and mitochondrial dysfunction during the pathogenesis of diabetic retinopathy. Oxid Med Cell Longev  2018,2018,1-12","journal-title":"Oxid Med Cell Longev"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2017.09.031","volume":"411","author":"Shukla K.","year":"2017","unstructured":"Shukla K.; Sonowal H.; Saxena A.; Ramana K.V.; Srivastava S.K.; Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2\/HO-1\/AMPK pathway in colon cancer cells. Cancer Lett  2017,411,57-63","journal-title":"Cancer Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.exer.2008.01.009","volume":"86","author":"Szaflik J.P.","year":"2008","unstructured":"Szaflik J.P.; Majsterek I.; Kowalski M.; Rusin P.; Sobczuk A.; Borucka A.I.; Szaflik J.; Blasiak J.; Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy. Exp Eye Res  2008,86(4),647-652","journal-title":"Exp Eye Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/niox.2001.0419","volume":"6","author":"Ellis E.A.","year":"2002","unstructured":"Ellis E.A.; Guberski D.L.; Hutson B.; Grant M.B.; Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ\/WOR rat. Nitric Oxide  2002,6(3),295-304","journal-title":"Nitric Oxide"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/all.14600","volume":"76","author":"Perkins T.N.","year":"2021","unstructured":"Perkins T.N.; Donnell M.L.; Oury T.D.; The axis of the receptor for advanced glycation endproducts in asthma and allergic airway disease. Allergy  2021,76(5),1350-1366","journal-title":"Allergy"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fped.2019.00246","volume":"7","author":"Dharmage S.C.","year":"2019","unstructured":"Dharmage S.C.; Perret J.L.; Custovic A.; Epidemiology of Asthma in Children and Adults. Front Pediatr  2019,7,246","journal-title":"Front Pediatr"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1378\/chest.09-1895","volume":"137","author":"Murphy D.M.","year":"2010","unstructured":"Murphy D.M.; O\u2019Byrne P.M.; Recent advances in the pathophysiology of asthma. Chest  2010,137(6),1417-1426","journal-title":"Chest"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"e57442","DOI":"10.1371\/journal.pone.0057442","volume":"8","author":"Yadav U.C.S.","year":"2013","unstructured":"Yadav U.C.S.; Naura A.S.; Aguilera-Aguirre L.; Boldogh I.; Boulares H.A.; Calhoun W.J.; Ramana K.V.; Srivastava S.K.; Aldose reductase inhibition prevents allergic airway remodeling through PI3K\/AKT\/GSK3\u03b2 pathway in mice. PLoS One  2013,8(2),e57442","journal-title":"PLoS One"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.4049\/jimmunol.0901177","volume":"183","author":"Yadav U.C.S.","year":"2009","unstructured":"Yadav U.C.S.; Naura A.S.; Aguilera-Aguirre L.; Ramana K.V.; Boldogh I.; Sur S.; Boulares H.A.; Srivastava S.K.; Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice. J Immunol  2009,183(7),4723-4732","journal-title":"J Immunol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.redox.2016.11.003","volume":"11","author":"Wu J.","year":"2017","unstructured":"Wu J.; Jin Z.; Yan L.J.; Redox imbalance and mitochondrial abnormalities in the diabetic lung. Redox Biol  2017,11,51-59","journal-title":"Redox Biol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"Einarson T.R.","year":"2018","unstructured":"Einarson T.R.; Acs A.; Ludwig C.; Panton U.H.; Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol  2018,17(1),83","journal-title":"Cardiovasc Diabetol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e46549","DOI":"10.1371\/journal.pone.0046549","volume":"7","author":"Son N.H.","year":"2012","unstructured":"Son N.H.; Ananthakrishnan R.; Yu S.; Khan R.S.; Jiang H.; Ji R.; Akashi H.; Li Q.; O\u2019Shea K.; Homma S.; Goldberg I.J.; Ramasamy R.; Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia. PLoS One  2012,7(9),e46549","journal-title":"PLoS One"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"eabi6896","DOI":"10.1126\/sciadv.abi6896","volume":"7","author":"Lim W.F.","year":"2021","unstructured":"Lim W.F.; Forouhan M.; Roberts T.C.; Dabney J.; Ellerington R.; Speciale A.A.; Manzano R.; Lieto M.; Sangha G.; Banerjee S.; Concei\u00e7\u00e3o M.; Cravo L.; Biscans A.; Roux L.; Pourshafie N.; Grunseich C.; Duguez S.; Khvorova A.; Pennuto M.; Cortes C.J.; La Spada A.R.; Fischbeck K.H.; Wood M.J.A.; Rinaldi C.; Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity. Sci Adv  2021,7(34),eabi6896","journal-title":"Sci Adv"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/biom12040485","volume":"12","author":"Balestri F.","year":"2022","unstructured":"Balestri F.; Moschini R.; Mura U.; Cappiello M.; Del Corso A.; In search of differential inhibitors of aldose reductase. Biomolecules  2022,12(4),485","journal-title":"Biomolecules"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9624118","volume":"2022","author":"Julius A.","year":"2022","unstructured":"Julius A.; Renuka R.R.; Hopper W.; Babu Raghu P.; Rajendran S.; Srinivasan S.; Dharmalingam K.; Alanazi A.M.; Arokiyaraj S.; Prasath S.; Inhibition of aldose reductase by novel phytocompounds: A heuristic approach to treating diabetic retinopathy. Evid Based Complement Alternat Med  2022,2022,1-10","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2174\/1389200221666201016124125","volume":"21","author":"Grewal A.S.","year":"2020","unstructured":"Grewal A.S.; Thapa K.; Kanojia N.; Sharma N.; Singh S.; Natural compounds as source of aldose reductase (AR) inhibitors for the treatment of diabetic complications: A mini review. Curr Drug Metab  2020,21(14),1091-1116","journal-title":"Curr Drug Metab"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/life12081146","volume":"12","author":"Ansari P.","year":"2022","unstructured":"Ansari P.; Choudhury S.T.; Seidel V.; Rahman A.B.; Aziz M.A.; Richi A.E.; Rahman A.; Jafrin U.H.; Hannan J.M.A.; Abdel-Wahab Y.H.A.; Therapeutic potential of quercetin in the management of type-2 diabetes mellitus. Life (Basel)  2022,12(8),1146","journal-title":"Life (Basel)"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.2337\/dc09-1893","volume":"33","author":"Abhary S.","year":"2010","unstructured":"Abhary S.; Burdon K.P.; Laurie K.J.; Thorpe S.; Landers J.; Goold L.; Lake S.; Petrovsky N.; Craig J.E.; Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility. Diabetes Care  2010,33(8),1834-1836","journal-title":"Diabetes Care"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201025666230830125147","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220504\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201025666230830125147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T08:51:13Z","timestamp":1717059073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220504\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201025666230830125147","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}